Clinical Immunology, Neuropharmacology and Drug Development

Ethical and Regulatory Considerations in Neuropharmacology

This track invites submissions that explore the ethical and regulatory challenges associated with neuropharmacology research and drug development. Researchers should focus on issues such as informed consent, patient safety, and the approval process for new therapies. The track will cover both the ethical implications of emerging technologies, such as gene editing and AI, and the regulatory landscape for neuropharmacology. Attendees will gain insights into the complexities of navigating the ethical and regulatory environment in neuropharmacology, and the importance of balancing innovation with patient protection.